223
Views
15
CrossRef citations to date
0
Altmetric
Review

Craniopharyngioma treatment: an updated summary of important clinicopathological concepts

, , , &
Pages 261-282 | Received 31 Mar 2020, Accepted 13 May 2020, Published online: 02 Jul 2020

References

  • Buslei R, Rushing EJ, Giangaspero F, et al. Craniopharyngiomas. In: Louis DN, Ohgaki H, Wiestler OD, et al. editors. WHO classification of tumors of the central nervous system. 4th. Lyon: IARC Press; 2016. p. 324.
  • Burger PC, Sheithauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings. 4th ed. New York: Churchill Livingstone; 2002. p. 475–482.
  • Lopes MBS, Thapar K, Horvath E, et al. Neoplasms of the Sellar region. In: McLendon RE, Rosenblum MK, Bigner DD, editors. Russell and rubinstein’s pathology of tumors of the nervous system. 7th. London: Hodder Arnold; 2006; p. 722–732.
  • Muller H, Merchant TE, Warmuth-Metz M, et al. Craniopharyngioma. Nat Rev Dis Primers. 2019;5(1): 75.
  • Kubota T, Yamamoto S, Kohno H, et al. [Operative procedures of craniopharyngioma estimated by autopsy findings.]. Neurol Med Chir (Tokyo). 1980;20(4):341–354. (Japanese).
  • Prieto R, Pascual JM, Castro-Dufourny I, et al. Craniopharyngioma: surgical outcome as related to the degree of hypothalamic involvement. World Neurosurg. 2017;104:1006–1010.
  • Prieto R, Pascual JM, Subhi-Issa I, et al. Predictive factors for craniopharyngioma recurrence: A systematic review an illustrative case report of a rapid recurrence. World Neurosurg. 2013;79(5–6): 733–749.
  • De Vile CJ, Grant DB, Kendall BE, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg. 1996;85(1):73–81.
  • Pierre-Kahn A, Recassens C, Pinto G, et al. Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood A prospective series. Childs Nerv Syst. 2005;21(8–9):817–824.
  • Sadashivam S, Menon G, Abraham M, et al. Adult craniopharyngioma: the role of extent of resection in tumor recurrence and long-term functional outcome. Clin Neurol Neurosurg. 2020;192:105711.
  • Thompson D, Phipps K, Hayward R. Craniopharyngioma in childhood: our evidence-based approach to management. Childs Nerv Syst. 2005;21(8–9):660–668.
  • Fahlbusch R, Honegger J, Paulus W, et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg. 1999;90(2):237–250.
  • Duff J, Meyer FB, Ilstrup DM, et al. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery. 2000;46(2):291–302.
  • Elliot RE, Sands SA, Strom RG, et al. Craniopharyngioma clinical status scale: a standardized metric of preoperative function and posttreatment outcome. Neurosurg Focus. 2010;28(4):E2.
  • Cossu G, Jouanneau E, Cavallo LM, et al. Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section. Acta Neurochir. 2020;162(5):1159–1177.
  • Pascual JM, Prieto R, Carrasco R. Craniopharyngioma: 10 selected works that provide comprehensive and valuable insight into these complex tumors. World Neurosurg. 2019;122:710–712.
  • Engel J Über den hirnanhang und den trichter. inauguraldissertation. wien, gedruckt bei a. pichler’s sel. witwe. 1839.
  • Pascual JM, Prieto R, Rosdolsky M, et al. Joseph Engel (1816-1899),author of a meaningful dissertation on tumors of the pituitary infundibulum: his report on the oldest preserved whole craniopharyngioma specimen. Virchows Arch. 2019; DOI:10.1007/s00428-019-02664-z.
  • Zenker FA. Enorme cystendilbung im gehirn, vom hirnanhang ausgehend. Virchows Arch. 1857;12(4–5):454–466.
  • Erdheim J. Über hypophysengangsgeschwulste und Hirmcholesteatome. Sitzungsb Kais Akad Wissen Math Naturw Klin. 1904;113:537–726.
  • Babinski J. Tumeur du corps pituitaire sans acromégalie et avec arrêt de développement des organs génitaux. Rev Neurol. 1900;8:531–533.
  • Pascual JM, Prieto R, Rosdolsky M, et al. Cystic tumors of the pituitary infundibulum: seminal autopsy specimens (1899 to 1904) that allowed clinical-pathological craniopharyngioma characterization. Pituitary. 2018;21(4):393–405.
  • Mott FW, Barratt JOW. Three cases of tumor of the third ventricle. Arch Neurol Path Lab London County Asyl Claybury. 1899;1:417–439.
  • Fröhlich A. Ein fall von tumor der hypophysis cerebri ohne akromegalie. Wien Klin Rundschau. 1901;15:906–908.
  • Cushing H. Sexual infantilism with optic atrophy in cases of tumor affecting the hypophysis cerebri. J Nerv Ment Dis. 1906;33(11):704–716.
  • Pascual JM, Prieto R. Harvey Cushing and pituitary case number 3 (Mary D.): the origin of this most baffling problem in neurosurgery. Neurosurg Focus. 2016;41(1):E6.
  • Pascual JM, Rosdoslky M, Prieto R, et al. Jakob Erdheim (1874-1937): father of hypophyseal-duct tumors (craniopharyngiomas). Virchows Arch. 2015;467(4): 459–469.
  • Verga G. La Patologia Chirurgica dell’Ipofisi. Pavia: Tipografia Cooperativa; 1911.
  • Pascual JM, Prieto R, Mazzarello P. Sir Victor Horsley: pioneer craniopharyngioma surgeon. J Neurosurg. 2015;123(1):39–51.
  • Von Eiselsberg F. Operations upon the hypophysis. Ann Surg. 1910;52(1):1–14.
  • Halstead AE. Remarks on the operative treatment of tumors of the hypophysis with the report of two cases operated on by an oro-nasal method. Surg Gynecol Obstet. 1910;10:494–502.
  • Cushing H. The pituitary body and its disorders. Philadelphia: JB Lippincott; 1912.
  • Hirsch O. Die operative behandlung von hypophysistumoren nach endonasalen methoden. Arch Laryngol Rhinol. 1912;26:529–686.
  • Frazier CH. An approach to the hypophysis through the anterior cranial fossa. Ann Surg. 1913;57(2):145–150.
  • Prieto R, Pascual JM, Barrios L, et al. Frazier’s craniopharyngioma treatment: the pivotal role of the transfrontal approach. J Neurosurg. 2019;1–14. DOI:10.3171/2019.8.JNS191508
  • Cushing H. Psychic disturbances associated with disorders of the ductless glands. Am J Insanity. 1913;69:965–990.
  • Camus J, Roussy G. Polyurie expérimentale par lésions de la base du cerveau La polyurie dite hypophysaire. C R Sceances Soc Biol Fil. 1913;75:628–633.
  • Cushing H. Papers relating to the pituitary body, hypothalamus and parasympathetic nervous system. Springfield, IL: Charles C. Thomas; 1932.
  • Cushing H. Intracranial tumors notes upon a series of two thousand verified cases with surgical mortality percentages pertaining thereto. Springfield, IL: Charles C. Thomas; 1932.
  • Luger A. Zur kenntnis der im röntgenbild sichtbaren hirntumoren mit besonderer berücksichtigung der hypophysengangsgeschwülste. Fortschr Röntgenstr. 1914;21:605–614.
  • Heuer GJ. Surgical experiences with an intracranial approach to chiasmal lesions. Arch Surg. 1920;1(2):368–381.
  • Bailey P, Bremer F. Experimental diabetes insipidus and genital atrophy. Endocrinology. 1921;5(6):761–762.
  • Prieto R, Pascual JM. Percival S. Bailey: eminent scholar of neurosciences who revealed the workings of the hypothalamus through clinicopathological research on craniopharyngiomas. J Neurosurg. 2019;1–13. doi:10.3171/2019.3.JNS183145.
  • Prieto R, Pascual JM. Cushing’s dogged struggle against death: the astonishing case of a patient under cardiac arrest surviving craniopharyngioma surgery. J Neurosurg. 2020;1–10. DOI:10.3171/2019.11.JNS192487
  • Peet MM. Pituitary adamantinomas report of three cases. Arch Surg. 1927;15(6):829–854.
  • Van Bogaert L. The thalamic and Parkinsonian types of infundibular tumors. Arch Neurol Psychiatry. 1928;19(3):377–393.
  • Pascual JM, Prieto R, Barrios L. Harvey Cushing’s craniopharyngioma treatment: part 1. Identification and clinicopathological characterization of this challenging pituitary tumor. J Neurosurg. 2018;131(3):949–963.
  • Prieto R, Pascual JM, Barrios L. Harvey Cushing’s craniopharyngioma treatment: part 2. Surgical strategies and results of his pioneering series. J Neurosurg. 2018;131:946–978.
  • Bailey P. Craniopharyngiomas. Syndrome of the hypothalamus. In: Bailey P, editor. Intracranial Tumors. Springfield, IL: Charles C. Thomas Publisher; 1933. p. 113–137.
  • Foerster O, Gagel O. Ein fall von ependymcyste des iii. ventrikels. ein beitrag zur frage der beziehungen psychischer störungen zum hirnstamm. Z Gesamte Neurol Psychiatr. 1934;149(1):312–344.
  • Le Gros Clark WE, Beattie J, Riddoch G, et al. eds. The hypothalamus. morphological, functional, clinical and surgical aspects. Edinburgh:Oliver and Boyd; 1938.
  • Prieto R, Pascual JM. Norman M. dott, master of hypothalamic craniopharyngioma surgery: the decisive mentoring of harvey cushing and percival bailey at peter bent brigham hospital. J Neurosurg. 2017;127(4):927–940.
  • Carpenter RC, Chamberlin GW, Frazier CH. The treatment of hypophyseal stalk tumors by evacuation and irradiation. Am J Roentgenol Radium Ther. 1937;38:162–177.
  • Alpers BJ. Relation of the hypothalamus to disorders of personality Report of a case. Arch Neur Psych. 1937;38(2):291–303.
  • Williams M, Pennybacker J. Memory disturbances in third ventricle tumors. J Neurol Neurosurg Psychiatr. 1954;17(2):115–123.
  • Ingraham FD, Matson DD, McLaurin RL. Cortisone and ACTCH as an adjunct to the surgery of craniopharyngiomas. N Engl J Med. 1952;246(15):568–571.
  • Northfiled DW. Rathke-pouch tumours. Brain. 1957;80(3):293–312.
  • Hirsch O, Hamlin H. Symptomatology and treatment of the hypophyseal duct tumors. Confin Neurol. 1959;19(3):153–219.
  • Pertuiset B, Janny P, Allegre G, et al. Craniopharyngiomes simulat une tumeur antérieure du III ventricule. Presse Med. 1962;70:1846–1848.
  • Matson DD, Crigler JF Jr. Management of craniopharyngioma in childhood. J Neurosurg. 1969;30(4):377–390.
  • Kahn EA, Gosch HH, Seeger JF, et al. Forty-five years experience with the craniopharyngiomas. Surg Neurol. 1973;1(1):5–12.
  • Long DM, Chou SN. Transcallosal removal of craniopharyngiomas within the third ventricle. J Neurosurg. 1973;39(5):563–567.
  • Sweet WH. Radical surgical treatment of craniopharyngioma. Clin Neurosurg. 1976;23(CN_suppl_1):52–79.
  • King TT. Removal of intraventricular craniopharyngiomas through the lamina terminalis. Acta Neurochir. 1979;45(3–4):277–286.
  • Ciric IS, Cozzens JW. Craniopharyngiomas: transsphenoidal method of approach – for the virtuoso only? Clin Neurosurg. 1980;27:169–187.
  • Giangaspero F, Burger PC, Osborne DR, et al. Suprasellar papillary squamous epithelioma (“papillary craniopharyngioma”). Am J Surg Pathol. 1984;8(1):57–64.
  • Steno J. Microsurgical topography of craniopharyngiomas. Acta Neurchir (Suppl). 1985;35:94–100.
  • Yasargil MG, Curcic M, Kis M, et al. Total removal of craniopharyngiomas. approaches and long-term results in 144 patients. J Neurosurg. 1990;73(1): 3–11.
  • Raybaud C, Rabehanta P, Girard N. Aspects radiologiques des craniopharyngiomes. Neurochirurgie. 1991;37(1):44–58.
  • Harrison MJ, Morgello S, Post KD. Epithelial cystic lesions of the sellar and parasellar region: a continuum of ectodermal derivatives? J Neurosurg. 1994;80(6):1018–1025.
  • Crotty TB, Scheithauer BW, Young WF, et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83(2):206–214.
  • Sekine S, Shibata T, Kokubu A, et al. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002;161(6): 1997–2001.
  • Pascual JM, González-Llanos F, Barrios L, et al. Intraventricular craniopharyngiomas: topographical classification and surgical approach selected based on an extensive overview. Acta Neurochir (Wien). 2004;146(8):785–802.
  • Sainte-Rose C, Puget S, Wray A, et al. Craniopharyngioma: the pendulum of surgical management. Childs Nerv Syst. 2005;21(8–9): 691–695.
  • Gaston-Massuet C, Andoniaou CL, Signore M, et al. Increased wingless (wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci USA. 2011;108(28): 11482–11487.
  • Pascual JM, Prieto R, Carrasco R, et al. Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis. J Neurosurg. 2013;119(2):381–405.
  • Cavallo LM, Frank G, Cappabianca P, et al. The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients. J Neurosurg. 2014;121(1):100–113.
  • Brastianos PK, Taylor-Weiner A, Manley PE, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2): 161–165.
  • Aylwin SJ, Bodi I, Beaney R. Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary. 2016;19(5):544–546.
  • Martinez-Barbera JP, Andoniaou CL. Concise review: paracrine role of stem cell in pituitary tumors: a focus on adamantinomatous craniopharyngioma. Stem Cells. 2016;34(2):268–276.
  • Prieto R, Pascual JM, Rosdolsky M, et al. Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors. Neurosurg Focus. 2016;41(6): E13.
  • Qi S, Lu Y, Pan L, et al. Anatomic relations of the arachnoidea around the pituitary stalk: relevance for surgical removal of craniopharyngiomas. Acta Neurochir. 2011;153(4):785–796.
  • Qi S, Pan J, Lu Y. Craniopharyngiomas – classification and surgical treatment frontiers in neurosurgery. Sharjah:UAE, Bentham Science Publishers; 2017.
  • Prieto R, Pascual JM, Barrios L. Letter: A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery. 2019;85(5):E962–5.
  • Hölsken A, Sill M, Merkle J, et al. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun. 2016;4(1):20.
  • Prieto R, Pascual JM. Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview. Pituitary. 2018;21(4):431–442.
  • Pascual JM, Prieto R, Carrasco R, et al. Premio Sixto Obrador 2013. modelo topográfico de 3 ejes para el tratamiento quirúrgico de los craneofaringiomas. parte i: evolución histórica del diagnóstico topográfico y métodos de clasificación de los craneofaringiomas. Neurocirugía (Astur). 2014;25(4):154–169.
  • Berstein ML, Buchino JJ. The histologic similarities between craniopharyngioma and odontogenic lesions: a reappraisal. Oral Surg Oral Med Oral Pathol. 1983;56(5):502–511.
  • Sekine S, Takata T, Shibata T, et al. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology. 2004;45(6):573–579.
  • Van Gilder JC, Inukai J. Growth characteristics of experimental intracerebrally transplanted oral epithelium. J Neurosurg. 1973;38(5):608–615.
  • Petito CK, De Girolami U, Earle KM. Craniopharyngiomas: a clinical and pathological review. Cancer. 1976;37:1944–1952.
  • Prieto R, Pascual JM. Craniopharyngiomas with a mixed histological pattern: the missing link to the intriguing pathogenesis of adamantinomatous and papillary varieties? Neuropathology. 2013;33(6):682–686.
  • Zada G, Lin N, Ojerholm E, et al. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010;28(4): E4.
  • Apps JR, Carreno G, Gonzalez-Meljem JM, et al. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAP/ERK pathways as a novel therapeutic target. Acta Neuropathol. 2018;135(5):757-777.
  • Pascual JM, Carrasco R, Prieto R, et al. Craniopharyngioma classification. J Neurosurg. 2018;109:757–777.
  • Pascual JM, Prieto R, Carrasco R. Infundibulo-tuberal or not strictly intraventricular craniopharyngioma: evidence for a major topographical category. Acta Neurochir (Wien). 2011;153(12):2403–2426.
  • Prieto R, Pascual JM, Barrios L. Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images. AJNR Am J Neuroradiol. 2017;38(11):2073–2080..
  • Pascual JM, Prieto R, Castro Dufourny I, et al. Hypothalamus-referenced classification for craniopharyngiomas: evidence provided by the endoscopic endonasal approach. Neurosurg Rev. 2013;36(2):337–340.
  • Pascual JM, Prieto R, Carrasco R, et al. Premio Sixto Obrador 2013Modelo topográfico de 3 ejes para el tratamiento quirúrgico de los cranofaringiomas. Parte II: evidencias anatómicas y neurorradiológicas que definen el modelo de clasificación de 3 ejes y su utilidad para predecir el riesgo quirúrgico individual. Neurocirugía. 2014;25(4):154–169.
  • Prieto R, Pascual JM. Accurate craniopharyngioma topography for patient outcome improvement. World Neurosurg. 2014;82(3–4):e553–7.
  • Prieto R, Castro-Dufourny I, Carrasco R, et al. Craniopharyngioma recurrence: the impact of tumor topography. J Neurosurg. 2016;125(4):1043–1049.
  • Prieto R, Pascual JM. Craniopharyngiomas: an appropriate surgical treatment based on topographical and pathological concepts. OBM Neurobiol. 2018;2(4):1.
  • Prieto R, Pascual JM. Letter to the Editor. The craniopharyngioma-hypothalamus relationship. J Neurosurg. 2019;1–2. DOI:10.3171/2019.7.JNS191780
  • Puget S, Garnett M, Wray A, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg. 2007;106(1 Suppl Pediatrics):3–12.
  • Kassam AB, Gardner PA, Snyderman CH, et al. Expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum. J Neurosurg. 2008;108(4): 715–728.
  • Gardner PA, Kassam AB, Snyderman CH, et al. Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series. J Neurosurg. 2008;109(1):6–16.
  • Prieto R, Pascual JM, Rosdolsky M, et al. Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of the attachment to the hypothalamus. World Neurosurg. 2018;110:e404–26.
  • Pascual JM, Prieto R, Castro-Dufourny I, et al. Craniopharyngiomas primarily involving the hypothalamus: a model of neurosurgical lesions to elucidate the neurobiological basis of psychiatric disorders. World Neurosurg. 2018;120:e1245–78.
  • Pascual JM, Prieto R, Rosdolsky M. Craniopharyngiomas primarily affecting the hypothalamus. In: Swaab DF, Lucassen PJ, Kreier F, et al. editors. The Human Hypothalamus. Neuroendocrine disorders. Handbook of Clinical Neurology. Third series. Elsevier. 2021. In press.
  • Pascual JM, Prieto R, Carrasco R, et al. Letters to the Editor: craniopharyngioma adherence to the hypothalamus. Neurosurg Focus. 2014;37(2):1–7.
  • Castro-Dufourny I, Carrasco R, Prieto R, et al. Infundibulo-tuberal syndrome: the origins of clinical neuroendocrinology in France. Pituitary. 2015;18(6):838–843.
  • Castro-Dufourny I, Carrasco R, Prieto R, et al. The infundíbulo-tuberal syndrome caused by craniopharyngiomas: clinicopathological evidence from an historical French cohort (1705-1973). Pituitary. 2015;18(5):642–657.
  • Prieto R, Pascual JM, Barrios L. Optic chiasm distortions caused by craniopharyngiomas: clinical and magnetic resonance imaging correlation and influence on visual outcome. World Neurosurg. 2015;83(4):500–529.
  • Giese H, Haenig B, Haenig A, et al. Neurological and neuropsychological outcome after resection of craniopharyngiomas. J Neurosurg. 2019; DOI:10.3171/2018.10.JNS181557.
  • Gil-Simoes R, Pascual JM, Casas SP, et al. Intrachiasmatic craniopharyngioma: assessment of visual outcome with optical coherence tomography after complete surgical removal. Surg Neurol Int. 2019;10(1):7.
  • Maira G, Anile C, Rossi GF, et al. Surgical treatment of craniopharyngiomas: an evaluation of the transsphenoidal and pterional approaches. Neurosurgery. 1995;36(4):715–724.
  • Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg. 2002;97(1):3–11.
  • Caldarelli M, Massimi L, Tamburrini G, et al. Long-term of the surgical treatment of craniopharyngioma: the experience at the policlinico gemelli, catholic university, Rome. Childs Nerv Syst. 2005;21(8–9):747–757.
  • Chakrabarti I, Amar AP, Couldwell W, et al. Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngiomas. J Neurosurg. 2005;102(4):650–657.
  • Minamida Y, Mikami T, Hashi K, et al. Surgical management of the recurrence and regrowth of craniopharyngiomas. J Neurosurg. 2005;103(2):224–232.
  • Tomita T, Bowman RM. Craniopharyngiomas in children: surgical experience at children’s memorial hospital. Childs Nerv Syst. 2005;21(8–9):729–746.
  • Zuccaro G. Radical resection of craniopharyngioma. Childs Nerv Syst. 2005;21(8–9):679–690.
  • Shi SE, Wu B, Fan T, et al. Craniopharyngioma: surgical experience of 309 cases in China. Clin Neurol Neurosurg. 2008;110(2):151–159.
  • Zhang YQ, Ma AY, Wu ZB, et al. Radical resection of 202 pediatric craniopharyngiomas with special reference to the surgical approaches and hypothalamic protection. Pediatr Neurosurg. 2008;44(6):435–443.
  • Jung TY, Jung S, Choi JE, et al. Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation. J Neurosurg. 2009;111(3): 572–577.
  • Kitano M, Taneda M. Extended transsphenoidal surgery for suprasellar craniopharyngiomas: infrachiasmatic radical resection combined with or without suprachiasmatic trans-lamina terminalis approach. Surg Neurol. 2009;71(3):290–298.
  • Jane JA Jr, Prevedello DM, Alden TD, et al. The transsphenoidal resection of pediatric craniopharyngiomas: a case series. J Neurosurg Pediatr. 2010;5(1):49–60.
  • Yamada S, Fukuhara N, Oyama K, et al. Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery. World Neurosurg. 2010;74(2–3):320–330.
  • Mortini P, Losa M, Pozzobon G, et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg. 2011;114(5):1350–1359.
  • Hofmann BM, Höllig A, Strauss C, et al. Results after treatment of craniopharyngiomas: further experiences with 73 patients since 1997. J Neurosurg. 2012;116(2):373–384.
  • Zhao X, Yi X, Wang H, et al. An analysis of related factors of surgical results for patients with craniopharyngiomas. Clin Neurol Neurosurg. 2012;114(2):149–155.
  • Leng LZ, Greenfield J, Souweidane MM, et al. Endoscopic, endonasal resection of craniopharyngiomas: analysis of outcome including extent of resection, cerebrospinal fluid leak, return to preoperative productivity, and body mass index. Neurosurgery. 2012;70(1):110–124.
  • Koutourousiou M, Gardner PA, Fernandez-Miranda JC, et al. Endoscopic endonasal surgery for craniopharyngiomas: surgical outcome in 64 patients. J Neurosurg. 2013;119(5):1194–1207.
  • Sanhkla SK, Jayashankar N, Khan GM. Extended endoscopic endonasal transsphenoidal approach for retrochiasmatic craniopharyngioma: surgical technique and results. J Pediatr Neurosci. 2015;10(4):308–316.
  • Du C, Feng CY, Yuan XR, et al. Microsurgical management of craniopharyngiomas via a unilateral subfrontal approach: a retrospective study of 177 continuous cases. World Neurosurg. 2016;90:454–468.
  • Jeswani S, Nuño M, Wu A, et al. Comparative analysis of outcome following craniotomy and expanded endoscopic endonasal transsphenoidal resection of craniopharyngioma and related tumors: a single-institution study. J Neurosurg. 2016;124(3):627–638.
  • Morisako H, Goto T, Goto H, et al. Aggressive surgery based on an anatomical subclassification of craniopharyngiomas. Neurosurg Focus. 2016;41(6):E10.
  • Shi X, Zhou Z, Wu B, et al. Outcome of radical surgical resection for craniopharyngioma with hypothalamic preservation: a single-center, retrospective study of 1054 patients. World Neurosurg. 2017;102:167–180.
  • Patel VS, Thamboo A, Quon J, et al. Outcomes after endoscopic endonasal resection of craniopharyngiomas in the pediatric population. World Neurosurg. 2017;108:6–14.
  • Capatina C, Vintila M, Gherlan I, et al. Craniopharyngioma-clinical and therapeutic outcome data in a mixed cohort of adult and pediatric cases. Acta Endocrinol (Buc). 2018;14(4):549–555.
  • Yamada S, Fukuhara N, Yamaguchi-Okada M, et al. Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study. J Neurosurg Pediatr. 2018;21(6):549–562.
  • Tang B, Xie SH, Huang GL, et al. Clinical features and operative technique of transinfundibular craniopharyngioma. J Neurosurg. 2019;1–10. DOI:10.3171/2019.3.JNS181953.
  • Mazzatenta D, Zoli M, Guaraldi F, et al. Outcome of endoscopic endonasal surgery in pediatric craniopharyngiomas. World Neurosurg. 2020;134:e277–88.
  • Mende KC, Kellner T, Petersenn S, et al. Clinical situation, therapy and follow up of adult craniopharyngioma – report from the German craniopharyngioma registry. J Clin Endocrinol Metab. 2020;105(1):252–265.
  • Park HJ, Dho YS, Kim JH, et al. Recurrence rate and prognostic factors for the adult craniopharyngiomas in long-term follow-up. World Neurosurg. 2020;133:e211–17.
  • Mediero S, Nova S, Bravo-Ljubetic L, et al. Visual outcomes, visual fields, and optical coherence tomography in paediatric craniopharyngioma. Neuro-Ophthalmology. 2015;39(3):132–139.
  • Ben-Shlomo A, Melmed S. Hypothalamic regulation of the anterior pituitary function. In: Melmed S, editor. The pituitary. 4th ed. London: Academic Press, Elsevier; 2017. p. 23–45.
  • Clarke IJ, Campbell R, Smith JT, et al. Neuroendocrine control of reproduction. In: Fink G, Pfaff DW, Levine JE editors. Handbook of neuroendocrinology. London: Academic Press, Elsevier; 2012. p. 197–236.
  • De Vries L, Lazar L, Phillip M. Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab. 2003;16(5):703–710.
  • Claude H, Lhermitte J. Le syndrome infundibulaire dans un cas de tumeur du troisième ventricule. Presse Med. 1917;41:417–418.
  • Rodríguez EM, Blázquez JL, Guerra M. The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid. Peptides. 2010;31(4):757–776.
  • Sachs H. Neurosecretion The hypothalamo-neurophypophyseal complex, a model system. In: Lajtha A, editor. Handbook of neurochemistry. volume IV. Control mechanisms in the nervous system. New York: Plenum Press; 1970. p. 380–384.
  • Swaab DF. The human hypothalamus basic and clinical aspects. In: Aminoff MJ, Boller F, Swaab DF editors. Handbook of clinical neurology. part 1 (3rd series, vol 1). Volume 79. Amsterdam: Elsevier; 2003.
  • Young JK. Hunger, thirst, sex and sleep: how the brain controls our passions. Plymouth, UK: Rowman & Littlefield Publishers Inc; 2012.
  • Leng G. The heart of the brain. the hypothalamus and its hormones. Cambridge, Massachusetts: The MIT Press; 2018.
  • Lindholm J. Diabetes insipidus: historical aspects. Pituitary. 2004;7(1):33–38.
  • Srinivasan S, Ogle GD, Garnett SP, et al. Features of the metabolic syndrome after childhood crariopharyngioma. J Clin Endocrinol Metab. 2004;89(1):81–86.
  • Muller HL. Craniopharyngioma. Endocr Rev. 2014;35(3):513–543.
  • Roth CL, Gebhardt U, Müller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Sring). 2011;19(1):36–42.
  • Van Iersel L, Brokke KE, Adan RAH, et al. Pathophysiology and individualized treatment for hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review. Endocr Rev. 2019;40:193–235.
  • Mehren A, Özyurt J, Klampen PZ, et al. Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma. J Neurooncol. 2018;140(1):27–35.
  • García-Cáceres C, Balland E, Prevot V, et al. Role of astrocytes, microglia and tanycytes in brain control of systemic metabolism. Nat Neurosci. 2019;22(1):7–14.
  • Nuzzaci D, Cansell C, Liénard F, et al. Postprandial hyperglycemia stimulates neuroglial plasticity in hypothalamic POMC neurons after a balanced meal. Cell Rep. 2020;30(9):3067–3078.
  • Castro-Dufourny I, Carrasco R, Pascual JM. Hypothalamic obesity after craniopharyngioma surgery: treatment with a long acting glucagon like peptide 1 derived. Endocrinol Diabet Nutr. 2017;64(3):182–184.
  • Zoli M, Sambai L, Milanese L, et al. Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas. Neurosurg Focus. 2016;41(6):E12.
  • Savastano LE, Hollon TC, Barkan AL, et al. Korsakoff syndrome from retrochiasmatic suprasellar lesions: rapid reversal after relief of cerebral compression in 4 cases. J Neurosurg. 2018;128(6):1731–1736.
  • Litofsky NS, Levy ML, Apuzzo MLJ. Craniopharyngioma. In: Apuzzo MLJ, editor. Brain surgery. Complication avoidance and management. New York: Churchill Livingstone; 1993. p. 313–378.
  • Prieto R, Pascual JM, Hofecker V, et al. Craniopharyngioma adherence: a reappraisal of the evidence. Neurosurg Rev. 2018; DOI:10.1007/s10143-018-1010-9.
  • Prieto R, Pascual JM. Letter to the editor. the craniopharyngioma-hypothalamus relationship. J Neurosurg. 2019. DOI:10.3171/2019.7.JNS191780
  • Prieto R, Pascual JM. Letter to the Editor. Heterogeneous hypothalamic adhesion among third ventricle craniopharyngiomas. J Neurosurg. 2019;131(4):1340–1342.
  • Kunishio K, Sunami N, Yamamoto Y, et al. [An autopsy study on the origin of craniopharyngioma confined to the third ventricle. Case report.]. Neurol Med Chir (Tokyo). 1986;26(9):712–717.
  • Steno J, Malácek M, Bízik I. Tumor-third ventricular relationships in supradiaphragmatic craniopharyngiomas: correlation of morphological, magnetic resonance imaging, and operative findings. Neurosurgery. 2004;54(5):1051–1060.
  • Steno J. Craniopharyngiomas and suprasellar tumors. In: Ellenbogen RG, Abdulrauf SI, Sekhar LN, editors. Principles of neurological surgery. 3. Philadelphia: Elseviers/Saunders; 2013; p. 597–620.
  • Pascual JM, Prieto R, Carrasco R, et al. Response on craniopharyngiomas and the hypothalamus. J Neurosurg. 2013;119(6):1650–1656.
  • Pan J, Qi S, Lu Y, et al. Intraventricular craniopharyngioma: morphological analysis and outcome evaluation of 17 cases. Acta Neurochir. 2011;153(4): 773–784.
  • Kim EH, Ahn JY, Kim SH. Technique and outcome of endoscopy-assisted microscopic extended transsphenoidal surgery for suprasellar craniopharyngiomas. J Neurosurg. 2011;114(5):1338–1349.
  • Steno J, Bízik I, Steno A, et al. Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv Syst. 2011;27(1):41–54.
  • Gerganov V, Metwali H, Samii A, et al. Microsurgical resection of extensive craniopharyngiomas using a frontolateral approach: operative technique and outcome. J Neurosurg. 2014;120(2):559–570.
  • Rosenfeld A, Arrington D, Miller J, et al. A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol. 2014;50(1):4–10.
  • Yu T, Sun X, Ren X, et al. Intraventricular craniopharyngiomas: surgical management and outcome analyses in 24 cases. World Neurosurg. 2014;82(6):1209–1215.
  • Yano S, Hide T, Shinojima N. Surgical outcomes of endoscopic endonasal skull base surgery of craniopharyngiomas evaluated according to the degree of hypothalamic extension. World Neurosurg. 2017;100:288–296.
  • Alalade AF, Ogando-Rivas E, Boatey J, et al. Suprasellar and recurrent pediatric craniopharyngiomas: expanding indications for the extended endoscopic transsphenoidal approach. J Neurosurg Pediatr. 2018;21(1):72–80.
  • Andereggen L, Hess B, Andres R, et al. A ten-year follow-up study of treatment outcome of craniopharyngiomas. Swiss Med Wkly. 2018;148:w14521.
  • Apra C, Enachescu C, Lapras V, et al. Is gross total resection reasonable in adults with craniopharyngiomas with hypothalamic involvement? World Neurosurg. 2019;129:e803–e811.
  • Yang L, Xie SH, Fang C, et al. Preservation of hypothalamic function with endoscopic endonasal resection of hypothalamus-invaded craniopharyngiomas. World Neurosurg. 2019;132:e841–51.
  • Mandrell BN, LaRosa K, Hancock D, et al. Predictors of narcolepsy and hypersomnia due to medical disorder in pediatric craniopharyngioma. J Neurooncol. 2020; DOI:10.1007/s11060-020-03519-3.
  • Pereira A, Schmid EM, Schutte PJ, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharynioma. Clin Endocrinol (Oxf). 2005;62(2):197–204.
  • Pascual JM, Prieto R, Castro-Duforuny I, et al. Development of intracranial approaches for craniopharyngiomas: an analysis of the first 160 historical procedures. Neurosurg Focus. 2014;36(4): E13.
  • Apuzzo MLJ. Surgery of the third ventricle. 2nd ed. Baltimore: Williams & Wilkins; 1998.
  • Locatelli D, Levi D, Rampa F, et al. Endoscopic approach for the treatment of relapses in cystic craniopharyngiomas. Childs Nerv Syst. 2004;20(11–12):863–867.
  • Komotar RJ, Starke RM, Raper DM, et al. Endoscopic endonasal compared microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg. 2012;77(2):329–341.
  • De Divitiis E, Cappabianca P, Cavallo LM, et al. Extended endoscopic transsphenoidal approach for extrasellar craniopharyngiomas. Neurosurgery. 2007;61(5 Suppl 2):219–228.
  • Wang EW, Zanation AM, Gardner PA, et al. ICAR: endoscopic skull-base surgery. Int Forum Allergy Rhinol. 2019;9:S145–65.
  • Turel MK, Tsermoulas G, Gonen L, et al. Management and outcome of recurrent adult craniopharyngiomas: an analysis of 42 cases with long term follow-up. Neurosurg Focus. 2016;41(6):E11.
  • Runtenberg MS, Rotondo RL, D R, et al. Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study. J Clin Neurooncol. 2020; DOI:10.1007/s11060-020-03432-9.
  • Yang I, Sughrue ME, Rutkowski MJ, et al. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus. 2010;28(4):E5.
  • Schoenfeld A, Pekmezci M, Barnes MJ, et al. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neuro-Oncol. 2012;108(1):133–139.
  • Wang G, Zhang X, Feng M, et al. Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngiomas: a meta-analysis. J Surg Res. 2018;226:131–139.
  • Zhang C, Verma V, Lyden ER, et al. The role of definitive radiotherapy in craniopharyngioma: a SEER analysis. Am J Clin Oncol. 2018;41(8):807–812.
  • Kobayashi T, Kida Y, Hasegawa T. Long-term results of gamma knife surgery for craniopharyngioma. Neurosurg Focus. 2003;14(5):E13.
  • Minniti G, Esposito V, Amichetti M, et al. The role of fractionated radiotherapy and radio surgery in the management of patients with craniopharyngioma. Neurosurg Rev. 2009;32(2):125–132.
  • Clark AJ, Cage TA, Aranda D, et al. Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr. 2012;10(4):293–301.
  • Marcus HJ, Rasul FT, Husseinz Z, et al. Craniopharyngioma in children: trends from a third consecutive single-center cohort study. J Neurosurg Pediatr. 2019; DOI:10.3171/2019.10.PEDS19147.
  • Conti A, Pontoriero A, Ghetti I, et al. Benefits of image-guided stereotactic hypofractionated radiation therapy as adjuvant treatment of craniopharyngiomas A review. Child’s Nerv Syst. 2019;35(1):53–61.
  • Combs SE, Thilmann C, Huber PE, et al. Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer. 2007;109(11):2308–2314.
  • Chiou SM, Lunsford LD, Niranjan A, et al. Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro Oncol. 2001;3(3):159–166.
  • Agrawal A, Fersht N, Brada M. Radiotherapy for craniopharyngioma. Pituitary. 2013;16(1):26–33.
  • Lee CC, Yang HC, Chen CJ, et al. Gamma knife surgery for craniopharyngioma: report on a 20-year experience. J Neurosurg. 2014;121(Suppl_2):167–178.
  • Mrowczynski OD, Langan ST, Rizk EB. Craniopharyngiomas: a systematic review and evaluation of the current intratumoral treatment landscape. Clin Neurol Neurosurg. 2018;166:124–130.
  • Whelan R, Prince E, Gilani A, et al. The inflammatory milieu of adamantinomatous craniopharyngioma and its implications for treatment. J Clin Med. 2020;9(2):519.
  • Martinez-Barbera JP, Andoniaou CL. Biological behavior of craniopharyngiomas. Neuroendocrinology. 2020. DOI:10.1159/0005067904
  • Hofmann BM, Nimsky C, Fahlbusch R. Benefit of 1.5-T intraoperative MR imaging in the surgical treatment of craniopharyngiomas. Acta Neurochir. 2011;153(7):1377–1390.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.